WEE1 and ovarian carcinoma: Slipicevic et al. 21 utilized immunohistochemistry to assess WEE1 expression in ovarian cancer, revealing that recurrent patients, particularly those with prior chemotherapy experience, exhibited elevated WEE1 levels, correlating with reduced overall survival.